Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review.

Rheumatology and Therapy
Anja St Clair-JonesPhilipp Sewerin

Abstract

Injection-site pain (ISP) is a subjective side effect that is commonly reported with the subcutaneous administration of biological agents, yet it may only be a concern to some. Multiple factors related to the product formulation, such as pH, volume and excipients, and/or to the injection process have the potential to contribute to ISP, while patient-related factors, such as low body weight, gender and age, can make an individual more susceptible to experiencing ISP. While total elimination of ISP remains unlikely with any subcutaneously administered agent, it can be minimised by helping the patient to develop a confident and competent injection technique via robust and effective training. Careful management of patient expectations along with open discussion regarding the potential risk of ISP may serve to minimise treatment-related anxieties and, importantly, allow the patient to remain in control of his/her treatment. Other interventions to help minimise ISP include psychological interventions, allowing biologics to reach room temperature prior to injection, using the most suitable injection device for the individual patient and selecting an alternative drug formulation, when available. Productive patient-physician communicati...Continue Reading

References

Jul 1, 1996·The Annals of Pharmacotherapy·J T JørgensenL Musaeus
Mar 16, 2000·Journal of Advanced Nursing·M A Rodger, L King
Jul 19, 2006·Somatosensory & Motor Research·Lars Arendt-NielsenPeter Bjerring
Aug 29, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Claus Peter SchmittFranz Schaefer
Apr 4, 2007·Postgraduate Medical Journal·Annabel KuekAndrew J K Ostör
Jul 29, 2010·Arthritis Care & Research·Alicia J Zbehlik, Lin A Brown
Nov 26, 2010·Current Medical Research and Opinion·Jeffrey R CurtisKevin Hansbrough
Apr 19, 2011·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Eileen R ManabatDajie Wang
Jan 22, 2013·Expert Opinion on Drug Safety·Giuseppe MurdacaFrancesco Puppo
Apr 12, 2013·European Journal of Pain : EJP·R C PriceP Schweinhardt
Jun 2, 2015·International Journal of Pharmaceutics·Wei Wang
Nov 5, 2015·United European Gastroenterology Journal·Justin Côté-DaigneaultPierre Poitras
Nov 8, 2015·Arthritis & Rheumatology·Jasvinder A SinghTimothy McAlindon
Jul 6, 2016·Journal of Pharmaceutical Sciences·Roman MathaesHanns-Christian Mahler
Jul 31, 2016·Dermatology and Therapy·Michael AbroukWilson Liao
Nov 5, 2016·Expert Opinion on Drug Delivery·Tilman R RohrerAnne-Marie Kappelgaard
Nov 2, 2016·Expert Opinion on Drug Delivery·Barbara DomańskaMichael Schiff
May 18, 2017·Journal of Crohn's & Colitis·Marcus HarbordUNKNOWN European Crohn’s and Colitis Organisation [ECCO]
Oct 11, 2017·Journal of Diabetes Science and Technology·Eric ZijlstraThomas Forst
Nov 7, 2017·International Journal of Molecular Sciences·Kirsten Rønholt, Lars Iversen
Apr 24, 2018·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Josefine BunkeMalin Malmsjö

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.